Levels, a software company providing real-time feedback on how food affects your health, announced today that it has raised $7 million in series A funding. Following a $38 million Series A round in April 2022, the extension strengthens ties with existing and new individual investors and funds such as TriplePoint Capital. Levels is a mobile application that uses data from biosensors and other sources, such as Apple Health, to show people how food affects their health.
Levels have raised more than $55 million to date to address the metabolic health crisis. a16z, Trust Ventures, and Shrug Capital are among the existing investors, as are notable founders and the Levels member community.
Levels’ mission of providing members with the tools and education they need to improve their health continues with the completion of this funding extension.
The additional funding allows the company to broaden access to its comprehensive suite of member services, which includes: the Levels app, which provides real-time feedback and guidance to help members improve their nutrition, exercise, sleep, and other habits; an engaged community; educational materials and expert insights, including a podcast and blog; and access to continuous glucose monitors (CGMs) and on-demand blood testing to track metabolic markers.
Levels help to see how food affects your health, empowering you with the tools needed to achieve health goals and improve healthspan. By leveraging data shared by members from biosensors like continuous glucose monitors, Levels provides real-time feedback on how diet and lifestyle choices impact metabolic health.
